Suven Life Sciences, a Hyderabad-based life sciences company, has announced that it has bagged a Rs 20-crore custom synthesis order for a phase III drug. | |
| According to a press release, Suven has initiated more than 300 projects under the contract research and manufacturing services (CRAMS) business model. |
| |
| Of these, 52 are active at various stages of clinical development by the innovators "� 26 projects are in phase I, 21 in phase II and 5 are in phase III. |
| |
| Recently, one of the phase II projects moved into phase III resulting in an order of Rs 20 crore for an intermediate, which has to be supplied within the next six months. With this, Suven's total pending order position is at $10 million. |
| |
|
| |
